These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33360156)

  • 1. Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment.
    Ghafouri-Fard S; Shoorei H; Abak A; Abbas Raza SH; Pichler M; Taheri M
    Biomed Pharmacother; 2021 Feb; 134():111172. PubMed ID: 33360156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
    Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
    Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hacking the Cancer Genome: Profiling Therapeutically Actionable Long Non-coding RNAs Using CRISPR-Cas9 Screening.
    Esposito R; Bosch N; Lanzós A; Polidori T; Pulido-Quetglas C; Johnson R
    Cancer Cell; 2019 Apr; 35(4):545-557. PubMed ID: 30827888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.
    Venkatesh J; Wasson MD; Brown JM; Fernando W; Marcato P
    Cancer Lett; 2021 Jul; 509():81-88. PubMed ID: 33848519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs: A view to kill ovarian cancer.
    Zamaraev AV; Volik PI; Sukhikh GT; Kopeina GS; Zhivotovsky B
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188584. PubMed ID: 34157315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of non-coding RNAs in hematological malignancies.
    Ghafouri-Fard S; Esmaeili M; Taheri M
    Eur J Pharmacol; 2020 May; 875():172976. PubMed ID: 32112777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis.
    Wang J; Ye C; Liu J; Hu Y
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1034-1040. PubMed ID: 29777711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of miRNAs and lncRNAs in conferring resistance to doxorubicin.
    Taheri M; Mahmud Hussen B; Tondro Anamag F; Shoorei H; Dinger ME; Ghafouri-Fard S
    J Drug Target; 2022 Jan; 30(1):1-21. PubMed ID: 33788650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity.
    Mahabady MK; Mirzaei S; Saebfar H; Gholami MH; Zabolian A; Hushmandi K; Hashemi F; Tajik F; Hashemi M; Kumar AP; Aref AR; Zarrabi A; Khan H; Hamblin MR; Nuri Ertas Y; Samarghandian S
    J Cell Physiol; 2022 May; 237(5):2309-2344. PubMed ID: 35437787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs as novel therapeutic targets in cancer.
    Lavorgna G; Vago R; Sarmini M; Montorsi F; Salonia A; Bellone M
    Pharmacol Res; 2016 Aug; 110():131-138. PubMed ID: 27210721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy-mediating microRNAs in cancer chemoresistance.
    Jing Y; Liang W; Liu J; Zhang L; Wei J; Yang J; Zhang Y; Huang Z
    Cell Biol Toxicol; 2020 Dec; 36(6):517-536. PubMed ID: 32875398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of long non-coding RNAs in drug resistance of cancer.
    Zhang HD; Jiang LH; Zhong SL; Li J; Sun DW; Hou JC; Wang DD; Zhou SY; Tang JH
    Clin Genet; 2021 Jan; 99(1):84-92. PubMed ID: 32583420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of propofol on cancer development and chemotherapy: Potential mechanisms.
    Jiang S; Liu Y; Huang L; Zhang F; Kang R
    Eur J Pharmacol; 2018 Jul; 831():46-51. PubMed ID: 29654781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel.
    Mao BD; Xu P; Xu P; Zhong Y; Ding WW; Meng QZ
    J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNAs regulate angiogenic processes.
    Ghafouri-Fard S; Shoorei H; Mohaqiq M; Taheri M
    Vascul Pharmacol; 2020; 133-134():106778. PubMed ID: 32784009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug Development.
    Çetinkaya M; Baran Y
    Curr Pharm Biotechnol; 2023; 24(7):913-925. PubMed ID: 35927824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting long non-coding RNAs in cancers: progress and prospects.
    Li CH; Chen Y
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNAs in the doxorubicin resistance of cancer cells.
    Ashrafizaveh S; Ashrafizadeh M; Zarrabi A; Husmandi K; Zabolian A; Shahinozzaman M; Aref AR; Hamblin MR; Nabavi N; Crea F; Wang Y; Ahn KS
    Cancer Lett; 2021 Jun; 508():104-114. PubMed ID: 33766750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.